Exosomes derived from MSC as drug system in osteoarthritis therapy
Osteoarthritis (OA) is the most common degenerative disease of the joint with irreversible cartilage damage as the main pathological feature. With the development of regenerative medicine, mesenchymal stem cells (MSCs) have been found to have strong therapeutic potential. However, intraarticular MSC...
Päätekijät: | Shuzhan Wen, Xin Huang, Jingchun Ma, Guanglei Zhao, Tiancong Ma, Kangming Chen, Gangyong Huang, Jie Chen, Jingsheng Shi, Siqun Wang |
---|---|
Aineistotyyppi: | Artikkeli |
Kieli: | English |
Julkaistu: |
Frontiers Media S.A.
2024-03-01
|
Sarja: | Frontiers in Bioengineering and Biotechnology |
Aiheet: | |
Linkit: | https://www.frontiersin.org/articles/10.3389/fbioe.2024.1331218/full |
Samankaltaisia teoksia
-
Engineering of MSC-Derived Exosomes: A Promising Cell-Free Therapy for Osteoarthritis
Tekijä: Jin Cheng, et al.
Julkaistu: (2022-07-01) -
The role and underlying mechanism of dental pulp stem cell-derived exosomal miR-31 in the treatment of osteoarthritis by targeting mTOR to enhance chondrocyte autophagy levels
Tekijä: Guanglei Zhao, et al.
Julkaistu: (2023-01-01) -
Enhancement of the therapeutic efficacy of mesenchymal stem cell-derived exosomes in osteoarthritis
Tekijä: Zehao Zhang, et al.
Julkaistu: (2023-09-01) -
Human Bone Mesenchymal Stem Cell-Derived Exosomes Inhibit IL-1β-Induced Inflammation in Osteoarthritis Chondrocytes
Tekijä: Liping Zhou, et al.
Julkaistu: (2021-09-01) -
Exosomes treating osteoarthritis: hope with challenge
Tekijä: Congxiao Wu, et al.
Julkaistu: (2023-01-01)